Quantitative profile of estrogen receptor variants/isoforms in Taiwanese women with breast cancer

被引:11
作者
Hsiao, W. -C.
Cho, W. -C.
Lin, P. -W.
Lin, S. -L.
Lee, W. -Y.
Young, K. -C.
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Surg, Tainan 70101, Taiwan
[3] Chiayi Hosp, Dept Surg, Tainan, Taiwan
[4] Chimei Hosp, Dept Pathol, Tainan, Taiwan
来源
EJSO | 2006年 / 32卷 / 05期
关键词
estrogen receptor; exon-skipping variant; isoform; breast cancer tissue; real-time PCR;
D O I
10.1016/j.ejso.2006.02.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aim: To quantify ER variants/isoforms for women with breast cancer in Taiwan, an area with remarkably low breast cancer rates, but with an early onset and poor prognosis. Methods: Real-time PCR technology was exploited to quantify mRNAs of ER alpha, ER alpha E3 Delta, ER alpha E5 Delta, ER alpha E7 Delta and ER beta, in 49 breast cancer and paired adjacent normal tissues. Clinical parameters were assembled and tested for assocation with the ER expression. Results: Comparison of cancer and matched normal samples showed significantly decreased ER beta (p < 0.001) in cancer tissues, and constant amounts of ERa and their variants. The results revealed significantly lower ER alpha E7 Delta/ER alpha (p = 0.030) and ER beta/ER alpha (p = 0.035) ratios in patients with lymph node (LN) metastasis than in those without LN metastasis. Conclusion: Our data suggests that ER alpha E7 Delta and ER beta may regulate ER alpha in normal human breast tissue. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:492 / 497
页数:6
相关论文
共 32 条
[1]
Anandappa SY, 2000, INT J CANCER, V88, P209, DOI 10.1002/1097-0215(20001015)88:2<209::AID-IJC10>3.0.CO
[2]
2-M
[3]
Progesterone receptors - animal models and cell signaling in breast cancer - The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis [J].
Anderson, E .
BREAST CANCER RESEARCH, 2002, 4 (05) :197-201
[4]
Estrogen receptor β and breast cancer [J].
Balfe, PJ ;
McCann, AH ;
Welch, HM ;
Kerin, MJ .
EJSO, 2004, 30 (10) :1043-1050
[5]
An estrogen receptor-Lu splicing variant mediates both positive and negative effects on gene transcription [J].
Bollig, A ;
Miksicek, RJ .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (05) :634-649
[6]
Cancer epidemiology and control in Taiwan: a brief review [J].
Chen, CJ ;
You, SL ;
Lin, LH ;
Hsu, WL ;
Yang, YW .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 :S66-S81
[7]
Unique features of breast cancer in Taiwan [J].
Cheng, SH ;
Tsou, MH ;
Liu, MC ;
Jian, JJ ;
Cheng, JCH ;
Leu, SY ;
Hsieh, CY ;
Huang, AT .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 63 (03) :213-223
[8]
Loss of an estrogen receptor isoform (ER alpha Delta 3) in breast cancer and the consequences of its reexpression: Interference with estrogen-stimulated properties of malignant transformation [J].
Erenburg, I ;
Schachter, B ;
Lopez, RMY ;
Ossowski, L .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (13) :2004-2015
[9]
Steroid hormone interactions with target cells: Cross talk between membrane and nuclear pathways [J].
Farach-Carson, MC ;
Davis, PJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :839-845
[10]
Identification of a new isoform of the human estrogen receptor-alpha (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1 [J].
Flouriot, G ;
Brand, H ;
Denger, S ;
Metivier, R ;
Kos, M ;
Reid, G ;
Sonntag-Buck, V ;
Gannon, F .
EMBO JOURNAL, 2000, 19 (17) :4688-4700